NEW YORK (GenomeWeb) – Israeli biotech firm MeMed said that it has won a €2.3 million ($2.6 million) grant from the European Commission to support clinical testing of its ImmunoXpert test, a protein diagnostic for distinguishing between bacterial and viral infections.

According to the company, the funds will be used to put the test in pediatric departments in Italy and Germany. It aims to monitor 1,200 children with either respiratory tract infections or fevers without source, assessing both the clinical utility and cost-effectiveness of the test.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Researchers find that a personalized medicine approach could help people who experience pain while taking statins, New Scientist reports.

US National Science Foundation is continuing its responsible research conduct training policy despite its flaws, ScienceInsider reports.

A CRISPR-themed meeting explored how the tool could and should be used, Wired reports.

In Science this week: database of proteins' effects on cancer, targeted error correction sequencing, and more.

Sponsored by

This online, interactive seminar will answer researchers’ most pressing questions about how to gain outstanding research results from proteomic studies.